Total Payments
$1.1M
2024 Payments
$208,990
Companies
28
Transactions
1,828
Medicare Patients
4,651
Medicare Billing
$519,818
Payment Breakdown by Category
Other$893,689 (83.6%)
Travel$138,586 (13.0%)
Food & Beverage$26,973 (2.5%)
Consulting$9,615 (0.9%)
Education$21.46 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $807,062 | 312 | 75.5% |
| Travel and Lodging | $138,586 | 883 | 13.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $86,500 | 26 | 8.1% |
| Food and Beverage | $26,973 | 595 | 2.5% |
| Consulting Fee | $9,615 | 5 | 0.9% |
| Long term medical supply or device loan | $127.22 | 1 | 0.0% |
| Education | $21.46 | 2 | 0.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$1.1M
1,824 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NESTLE HEALTHCARE NUTRITION INC. | $275,405 | 365 | $0 (2023) |
| Allergan, Inc. | $243,961 | 600 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $110,609 | 172 | $0 (2017) |
| Synergy Pharmaceuticals Inc | $105,178 | 208 | $0 (2018) |
| AIMMUNE THERAPEUTICS, INC. | $102,004 | 81 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $99,875 | 156 | $0 (2024) |
| ABBVIE INC. | $85,438 | 126 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $24,349 | 32 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $11,532 | 24 | $0 (2017) |
| Ironwood Pharmaceuticals, Inc | $7,784 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $208,990 | 267 | AIMMUNE THERAPEUTICS, INC. ($102,004) |
| 2023 | $74,820 | 112 | NESTLE HEALTHCARE NUTRITION INC. ($59,793) |
| 2022 | $122,459 | 188 | Nestle HealthCare Nutrition Inc. ($95,467) |
| 2021 | $106,900 | 127 | Nestle HealthCare Nutrition Inc. ($102,516) |
| 2020 | $52,631 | 108 | Allergan, Inc. ($25,579) |
| 2019 | $43,881 | 112 | Allergan Inc. ($22,651) |
| 2018 | $133,412 | 244 | Allergan Inc. ($85,829) |
| 2017 | $325,791 | 670 | Valeant Pharmaceuticals North America LLC ($110,609) |
All Payment Transactions
1,828 individual payment records from CMS Open Payments — Page 1 of 74
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $214.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $147.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $44.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,010.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: GI | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $474.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $179.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $97.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $33.26 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,750.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,440.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,290.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $12.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $42.48 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $626.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,010.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $25.46 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,225 | 1,240 | $647,095 | $132,638 |
| 2022 | 10 | 1,151 | 1,168 | $649,097 | $124,019 |
| 2021 | 11 | 1,031 | 1,055 | $600,345 | $118,260 |
| 2020 | 9 | 1,244 | 1,291 | $718,929 | $144,900 |
Total Patients
4,651
Total Services
4,754
Medicare Billing
$519,818
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 203 | 203 | $190,008 | $31,385 | 16.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 200 | 200 | $74,400 | $21,278 | 28.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 110 | 110 | $85,140 | $19,253 | 22.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 164 | 168 | $104,160 | $14,076 | 13.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 75 | 75 | $58,050 | $13,209 | 22.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 190 | 190 | $45,980 | $10,447 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 125 | $30,625 | $9,724 | 31.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 33 | 33 | $36,564 | $6,785 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 136 | $22,168 | $6,481 | 29.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 237 | 238 | $222,768 | $33,715 | 15.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 208 | 208 | $77,376 | $19,997 | 25.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 84 | 84 | $65,016 | $15,061 | 23.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 74 | 74 | $57,276 | $13,081 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 166 | 179 | $43,855 | $12,659 | 28.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 135 | 137 | $84,940 | $10,786 | 12.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 165 | 165 | $39,930 | $8,029 | 20.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 36 | 36 | $39,888 | $7,151 | 17.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $13,158 | $1,887 | 14.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 30 | $4,890 | $1,654 | 33.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 239 | 239 | $223,704 | $36,237 | 16.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 223 | 223 | $82,956 | $20,903 | 25.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 81 | 81 | $62,694 | $14,857 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 166 | 184 | $45,080 | $12,996 | 28.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 129 | 134 | $83,080 | $10,573 | 12.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 41 | 41 | $31,734 | $7,533 | 23.7% |
About Dr. Daniel Meline, MD
Dr. Daniel Meline, MD is a Gastroenterology healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982714960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Meline, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $208,990 received in 2024. These payments were reported across 1,828 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($807,062).
As a Medicare-enrolled provider, Meline has provided services to 4,651 Medicare beneficiaries, totaling 4,754 services with total Medicare billing of $519,818. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Scottsdale, AZ
- Active Since 08/30/2006
- Last Updated 02/17/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1982714960
Products in Payments
- ZENPEP (Drug) $399,721
- LINZESS (Drug) $239,511
- Trulance (Drug) $105,178
- VOQUEZNA (Drug) $99,875
- XIFAXAN (Drug) $92,979
- CREON (Drug) $25,206
- Amitiza (Drug) $24,349
- Creon (Drug) $15,817
- APRISO (Drug) $12,913
- PREPOPIK (Drug) $11,532
- Linzess (Drug) $7,648
- VIBERZI (Drug) $6,316
- Alinia Tablets 500mg 30 count bottle (Drug) $1,309
- Epclusa (Drug) $235.10
- DUPIXENT (Biological) $230.02
- VRAYLAR (Drug) $134.92
- PlasmaTYPHOON (Device) $127.22
- Ozempic (Drug) $93.98
- SUCRAID (Drug) $65.57
- TREMFYA (Drug) $57.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Scottsdale
Dr. Pankaj Pasricha, Md, MD
Gastroenterology — Payments: $1.1M
Gastroenterology $1.1M
Dr. David Fleischer, M.d, M.D
Gastroenterology — Payments: $448,703
Gastroenterology $448,703
Woong Kim, M.d, M.D
Gastroenterology — Payments: $216,664
Gastroenterology $216,664
Dr. Manreet Kaur, M.d, M.D
Gastroenterology — Payments: $184,512
Gastroenterology $184,512
Norio Fukami, Md, MD
Gastroenterology — Payments: $177,621
Gastroenterology $177,621
Dr. Adam Harris, M.d, M.D
Gastroenterology — Payments: $137,122
Gastroenterology $137,122